medmix AG (MEDX) Stock Statistics & Valuation Metrics

medmix AG has a market cap or net worth of CHF507.53M. The enterprise value is CHF739.53M.

medmix AG has 41,262,370 shares outstanding. The number of shares has decreased by -2.65% in one year.

medmix AG’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 1.59%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, medmix AG had revenue of 483.90M and earned -7.40M in profits. Earnings per share was -0.17.

In the last 12 months, operating cash flow was 86.60M and capital expenditures -38.50M, giving a free cash flow of 48.10M billion.

medmix AG pays an annual dividend of CHF0.5, resulting in a dividend yield of 4.07%

medmix AG upcoming earnings date is Jul 23, 2025, TBA (Confirmed).

medmix AG as a current ratio of 1.60, with Debt / Equity ratio of 74.11%

In the past 12 months, medmix AG has paid 0.00 in taxes.

medmix AG EV to EBITDA ratio is 8.67, with an EV/FCF ratio of 15.38.

medmix AG has CHF96.20M in cash and marketable securities with CHF323.40M in debt, giving a net cash position of CHF227.20M billion.

Gross margin is 33.00%, with operating margin of 2.67%, and net profit margin of -1.53%.

The average price target for medmix AG is ―, which is 11.43% higher than the current price. The consensus rating is ―